Does the media refer more to LFST or AGL?

In the previous week, LifeStance Health Group had 2 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for LifeStance Health Group and 2 mentions for Agilon Health. LifeStance Health Group's average media sentiment score of 0.43 beat Agilon Health's score of 0.42 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate AGL or CRVL?

Agilon Health currently has a consensus target price of $102.25, indicating a potential upside of 21.06%. Given Agilon Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Agilon Health is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilon Health 2 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.27 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, AGL or CRVL?

CorVel has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilon Health $5.93B 0.24 -$391.35M -$14.27 N/A CorVel $958.53M 4.02 $110.34M $2.25 33.54

Is AGL or CRVL more profitable?

CorVel has a net margin of 11.72% compared to Agilon Health's net margin of -3.92%. CorVel's return on equity of 29.92% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets Agilon Health -3.92% -119.38% -16.85% CorVel 11.72% 29.92% 17.82%

Does the media prefer AGL or CRVL?

In the previous week, CorVel had 1 more articles in the media than Agilon Health. MarketBeat recorded 3 mentions for CorVel and 2 mentions for Agilon Health. CorVel's average media sentiment score of 0.46 beat Agilon Health's score of 0.42 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CorVel 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor OPCH or AGL?

In the previous week, Option Care Health and Option Care Health both had 2 articles in the media. Option Care Health's average media sentiment score of 1.24 beat Agilon Health's score of 0.42 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer AGL or AVAH?

In the previous week, Aveanna Healthcare had 4 more articles in the media than Agilon Health. MarketBeat recorded 6 mentions for Aveanna Healthcare and 2 mentions for Agilon Health. Aveanna Healthcare's average media sentiment score of 0.71 beat Agilon Health's score of 0.42 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aveanna Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, AGL or WGS?

GeneDx has lower revenue, but higher earnings than Agilon Health. GeneDx is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilon Health $5.93B 0.24 -$391.35M -$14.27 N/A GeneDx $427.54M 5.10 -$21.02M -$3.64 N/A

Is AGL or WGS more profitable?

Agilon Health has a net margin of -3.92% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets Agilon Health -3.92% -119.38% -16.85% GeneDx -23.41% 4.12% 2.26%

Does the media refer more to AGL or WGS?

In the previous week, GeneDx had 2 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for GeneDx and 2 mentions for Agilon Health. GeneDx's average media sentiment score of 0.82 beat Agilon Health's score of 0.42 indicating that GeneDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GeneDx 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Agilon Health (AGL) Competitors

$84.46 +2.18 (+2.65%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$84.28 -0.18 (-0.21%)

As of 10/2/2026 07:30 PM Eastern

Compare

AGL vs. LFST, CRVL, OPCH, AVAH, and WGS

Should you buy Agilon Health stock or one of its competitors? Agilon Health's main competitors and comparable companies include LifeStance Health Group (LFST), CorVel (CRVL), Option Care Health (OPCH), Aveanna Healthcare (AVAH), and GeneDx (WGS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Agilon Health compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

LifeStance Health Group has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.17	$9.66M	$0.13	91.00
Agilon Health	$5.93B	0.24	-$391.35M	-$14.27	N/A

In the previous week, LifeStance Health Group had 2 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for LifeStance Health Group and 2 mentions for Agilon Health. LifeStance Health Group's average media sentiment score of 0.43 beat Agilon Health's score of 0.42 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, meaning that its stock price is 198% more volatile than the broader market.

LifeStance Health Group presently has a consensus price target of $12.88, indicating a potential upside of 8.83%. Agilon Health has a consensus price target of $102.25, indicating a potential upside of 21.06%. Given Agilon Health's higher probable upside, analysts clearly believe Agilon Health is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Comparatively, 2.5% of Agilon Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LifeStance Health Group has a net margin of 3.19% compared to Agilon Health's net margin of -3.92%. LifeStance Health Group's return on equity of 3.39% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Agilon Health	-3.92%	-119.38%	-16.85%

Summary

LifeStance Health Group beats Agilon Health on 13 of the 16 factors compared between the two stocks.

How does Agilon Health compare to CorVel?

Agilon Health (NYSE:AGL) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

Agilon Health currently has a consensus target price of $102.25, indicating a potential upside of 21.06%. Given Agilon Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Agilon Health is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

CorVel has a net margin of 11.72% compared to Agilon Health's net margin of -3.92%. CorVel's return on equity of 29.92% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
CorVel	11.72%	29.92%	17.82%

51.4% of CorVel shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 39.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CorVel has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.24	-$391.35M	-$14.27	N/A
CorVel	$958.53M	4.02	$110.34M	$2.25	33.54

In the previous week, CorVel had 1 more articles in the media than Agilon Health. MarketBeat recorded 3 mentions for CorVel and 2 mentions for Agilon Health. CorVel's average media sentiment score of 0.46 beat Agilon Health's score of 0.42 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agilon Health has a beta of 2.98, indicating that its stock price is 198% more volatile than the broader market. Comparatively, CorVel has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market.

Summary

CorVel beats Agilon Health on 11 of the 16 factors compared between the two stocks.

How does Agilon Health compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

Option Care Health has a net margin of 3.68% compared to Agilon Health's net margin of -3.92%. Option Care Health's return on equity of 18.74% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.68%	18.74%	7.25%
Agilon Health	-3.92%	-119.38%	-16.85%

Option Care Health has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.65B	0.60	$207.59M	$1.33	17.02
Agilon Health	$5.93B	0.24	-$391.35M	-$14.27	N/A

98.1% of Option Care Health shares are owned by institutional investors. 1.7% of Option Care Health shares are owned by insiders. Comparatively, 2.5% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Option Care Health and Option Care Health both had 2 articles in the media. Option Care Health's average media sentiment score of 1.24 beat Agilon Health's score of 0.42 indicating that Option Care Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Option Care Health currently has a consensus target price of $29.92, suggesting a potential upside of 32.17%. Agilon Health has a consensus target price of $102.25, suggesting a potential upside of 21.06%. Given Option Care Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Option Care Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27

Option Care Health has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, meaning that its share price is 198% more volatile than the broader market.

Summary

Option Care Health beats Agilon Health on 12 of the 15 factors compared between the two stocks.

How does Agilon Health compare to Aveanna Healthcare?

Agilon Health (NYSE:AGL) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Aveanna Healthcare has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.24	-$391.35M	-$14.27	N/A
Aveanna Healthcare	$2.43B	1.13	$225.03M	$1.23	10.24

In the previous week, Aveanna Healthcare had 4 more articles in the media than Agilon Health. MarketBeat recorded 6 mentions for Aveanna Healthcare and 2 mentions for Agilon Health. Aveanna Healthcare's average media sentiment score of 0.71 beat Agilon Health's score of 0.42 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aveanna Healthcare	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilon Health presently has a consensus price target of $102.25, suggesting a potential upside of 21.06%. Aveanna Healthcare has a consensus price target of $14.06, suggesting a potential upside of 11.64%. Given Agilon Health's higher possible upside, equities analysts clearly believe Agilon Health is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Agilon Health has a beta of 2.98, meaning that its stock price is 198% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.95, meaning that its stock price is 95% more volatile than the broader market.

88.0% of Aveanna Healthcare shares are held by institutional investors. 2.5% of Agilon Health shares are held by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Aveanna Healthcare has a net margin of 10.56% compared to Agilon Health's net margin of -3.92%. Aveanna Healthcare's return on equity of 80.70% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
Aveanna Healthcare	10.56%	80.70%	7.42%

Summary

Aveanna Healthcare beats Agilon Health on 13 of the 16 factors compared between the two stocks.

How does Agilon Health compare to GeneDx?

Agilon Health (NYSE:AGL) and GeneDx (NASDAQ:WGS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

GeneDx has lower revenue, but higher earnings than Agilon Health. GeneDx is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.24	-$391.35M	-$14.27	N/A
GeneDx	$427.54M	5.10	-$21.02M	-$3.64	N/A

In the previous week, GeneDx had 2 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for GeneDx and 2 mentions for Agilon Health. GeneDx's average media sentiment score of 0.82 beat Agilon Health's score of 0.42 indicating that GeneDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GeneDx	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilon Health currently has a consensus target price of $102.25, suggesting a potential upside of 21.06%. GeneDx has a consensus target price of $90.86, suggesting a potential upside of 24.31%. Given GeneDx's stronger consensus rating and higher probable upside, analysts clearly believe GeneDx is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27
GeneDx	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89

61.7% of GeneDx shares are held by institutional investors. 2.5% of Agilon Health shares are held by insiders. Comparatively, 25.2% of GeneDx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Agilon Health has a net margin of -3.92% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
GeneDx	-23.41%	4.12%	2.26%

Agilon Health has a beta of 2.98, indicating that its share price is 198% more volatile than the broader market. Comparatively, GeneDx has a beta of 1.95, indicating that its share price is 95% more volatile than the broader market.

Summary

GeneDx beats Agilon Health on 13 of the 17 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AGL vs. The Competition

Export

Metric	Agilon Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.41B	$9.57B	$7.14B	$22.63B
Dividend Yield	N/A	2.61%	2.53%	3.73%
P/E Ratio	-5.92	34.21	274.83	27.75
Price / Sales	0.24	4.73	616.61	17.28
Price / Cash	N/A	120.59	77.60	38.88
Price / Book	11.05	5.15	10.93	4.64
Net Income	-$391.35M	$315.68M	$3.51B	$1.08B
7 Day Performance	4.70%	-2.59%	-2.00%	-1.06%
1 Month Performance	-2.32%	-3.19%	-6.15%	-5.49%
1 Year Performance	197.66%	7.93%	7.45%	5.13%

Agilon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AGL Agilon Health	1.8643 of 5 stars	$84.46 +2.6%	$102.25 +21.1%	+211.4%	$1.41B	$5.92B	N/A	856
LFST LifeStance Health Group	3.6613 of 5 stars	$11.84 flat	$12.88 +8.7%	+121.1%	$4.52B	$1.42B	91.08	10,961
CRVL CorVel	1.4284 of 5 stars	$73.84 -0.7%	N/A	+2.8%	$3.79B	$958.53M	32.82	5,239
OPCH Option Care Health	4.064 of 5 stars	$22.90 -0.7%	$29.92 +30.7%	-18.7%	$3.46B	$5.65B	17.22	8,266	Positive News
AVAH Aveanna Healthcare	4.3692 of 5 stars	$12.69 +2.3%	$14.06 +10.8%	+45.4%	$2.71B	$2.43B	10.32	35,500	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AGL) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilon Health (AGL) Competitors

AGL vs. LFST, CRVL, OPCH, AVAH, and WGS

How does Agilon Health compare to LifeStance Health Group?

Summary

How does Agilon Health compare to CorVel?

Summary

How does Agilon Health compare to Option Care Health?

Summary

How does Agilon Health compare to Aveanna Healthcare?

Summary

How does Agilon Health compare to GeneDx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilon Health (AGL) Competitors

AGL vs. LFST, CRVL, OPCH, AVAH, and WGS

How does Agilon Health compare to LifeStance Health Group?

Which has better earnings and valuation, LFST or AGL?

Does the media refer more to LFST or AGL?

Which has more volatility & risk, LFST or AGL?

Do analysts prefer LFST or AGL?

Do insiders and institutionals believe in LFST or AGL?

Is LFST or AGL more profitable?

Summary

How does Agilon Health compare to CorVel?

Do analysts rate AGL or CRVL?

Is AGL or CRVL more profitable?

Do institutionals & insiders believe in AGL or CRVL?

Which has better earnings and valuation, AGL or CRVL?

Does the media prefer AGL or CRVL?

Which has more risk and volatility, AGL or CRVL?

Summary

How does Agilon Health compare to Option Care Health?

Is OPCH or AGL more profitable?

Which has stronger valuation & earnings, OPCH or AGL?

Do insiders and institutionals hold more shares of OPCH or AGL?

Does the media favor OPCH or AGL?

Do analysts prefer OPCH or AGL?

Which has more volatility and risk, OPCH or AGL?

Summary

How does Agilon Health compare to Aveanna Healthcare?

Which has higher earnings & valuation, AGL or AVAH?

Does the media prefer AGL or AVAH?

Do analysts recommend AGL or AVAH?

Which has more risk and volatility, AGL or AVAH?

Do insiders & institutionals believe in AGL or AVAH?

Is AGL or AVAH more profitable?

Summary

How does Agilon Health compare to GeneDx?

Which has higher valuation and earnings, AGL or WGS?

Does the media refer more to AGL or WGS?

Do analysts prefer AGL or WGS?

Do insiders and institutionals hold more shares of AGL or WGS?

Is AGL or WGS more profitable?

Which has more risk and volatility, AGL or WGS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools